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Abstract Elderly people show a reduced protection
against new infections and a decreased response to
vaccines as a consequence of impairment of both
cellular and humoral immunity. In this paper we have
studied memory/naı¨ve B cells in the elderly, evalu-
ating surface immunoglobulin expression, production
of the pro- and anti-inflammatory cytokines, tumor
necrosis factor (TNF)-a and interleukin (IL)-10, and
presence of somatic hypermutation, focusing on
the IgG?IgD-CD27- double negative (DN) B cells
that are expanded in the elderly. Our results show that
naı¨ve B cells from young donors need a sufficiently
strong stimulus to be activated ‘‘in vitro’’, while naı¨ve
B cells from old subjects are able to produce IL-10
and TNF-a when stimulated ‘‘physiologically’’
(a-CD40/IL-4), suggesting that these cells might play
a role in the control of the immuno-inflammatory
environment in the elderly. In addition, in the elderly
there is an accumulation of DN B cells with a reduced
rate of somatic hypermutation. Thus, DN B lympho-
cytes may be exhausted cells that are expanded and
accumulate as a by-product of persistent stimulation
or impaired germinal center formation.
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Introduction
During ageing the humoral immune response is both
quantitatively and qualitatively diminished compared
with the immune response in young people. Many
authors have reported a reduced antibody specificity,
affinity, and isotype switch in the elderly (Weksler
2000; Frasca et al. 2004; Schenkein et al. 2008;
Cancro et al. 2009; Frasca et al. 2011). As a
consequence, old people show reduced protection
against new infectious agents and a decreased
response to vaccines (Frasca et al. 2010; Frasca and
Blomberg 2011). The generation and maintenance of
memory lymphocytes is a crucial event in the
immune response; in fact, these cells are essential
for effective vaccination and facilitate a recall
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(anamnestic) response to previously encountered
antigens (Weinberger et al. 2008). Studies on T cell
memory have suggested that the filling of the
immunological space with memory T cells renders
the immune system less able to respond to new
antigens (Franceschi et al. 2000a, b) contributing to
immunosenescence.
Memory B lymphocytes may also be important in
the older immune system, they can be distinguished
from naı¨ve B cells by the expression of switched
immunoglobulins and by the expression of the CD27
marker, although these markers don’t discriminate
unequivocally between naı¨ve and memory B cells
(Tangye and Hodgkin 2004; Fecteau et al. 2006;
Bulati et al. 2011). Subsets of memory B cells can be
easily, but not exhaustively, identified by the differ-
ent expression of surface IgD and CD27 (Shi et al.
2003). In addition, memory B cells are characterized
by the presence of somatic hypermutation in the
variable gene sequences of the immunoglobulins
(Klein et al. 1998).
In a previous paper we have reported the increase
in a population of double negative, IgD-CD27-,
(DN) B cells in the elderly that might be an exhausted
pool of memory B cells that fill the immunological B
cell space (Colonna-Romano et al. 2009), thus
reducing the availability of naı¨ve B cells that is
crucial for a response to new antigens. Moreover,
naı¨ve and memory B cells produce different pro- and
anti-inflammatory cytokines (Duddy et al. 2004;
Duddy et al. 2007; Sanz et al. 2007, 2008; Lund
2008) and might play a role in the generation of the
inflammatory environment typical of the elderly
(Licastro et al. 2005; Vasto et al. 2007).
In aged people a change in the B cell repertoire has
also been described, particularly in the heavy chain of
BCR. Indeed, an increased oligoclonality and a
reduced frequency of somatic hypermutation in the
elderly response to pneumococcal vaccination has
been reported (Kolibab et al. 2005). The consequence
is a collapse in B cell diversity in elderly people
which is correlated with poor health status in these
subjects (Gibson et al. 2009).
In this report, we have analyzed some character-
istics of DN B cells to evaluate whether these cells,
that are expanded in the elderly, play any role in the
ageing of the immune system and in the generation of
the immune-inflammatory environment of the
elderly.
Materials and methods
Subjects
Fifty-four healthy Sicilian subjects were studied, 25
young (age range 20–45 years) and 29 elderly (age
range 70–86). None of the selected subjects had
neoplastic, infectious, autoimmune diseases, or
received any medications influencing immune func-
tion at the time of the study. All subjects gave
informed consent according to Italian law. We have
performed the evaluation of surface immunoglobulin
expression on separated B cells of all subjects in the
study, but we have selected ten young and ten elderly
donors for B cell activation and cytokine detection,
and three samples of each age class for assessment of
somatic hypermutation.
Cell preparation and B cell enrichment
Peripheral blood mononuclear cells (PBMCs) were
isolated from heparinised venous blood by density
gradient centrifugation on Ficoll-Lympholyte (Cedar-
lane Laboratories Limited, Ontario, Canada). PBMCs
were adjusted to 1 9 106/ml in RPMI 1640 medium
(Euroclone, Devon, UK) supplemented with 10% heat-
inactivated fetal calf serum (Euroclone), 1% penicillin/
streptomicin, 10 mM HEPES, and 1 mM L-Glutamin.
B lymphocytes were separated from PBMCs by
immunomagnetic sorting, as described by Miltenyi
et al. (1990) using anti-CD19 magnetic microbeads
(MACS CD19 Multisort Microbeads; Miltenyi Biotec,
Aubum, CA, USA). Cells obtained from immunomag-
netic sorting were [98% CD19? lymphocytes, as
determined by flow cytometry analysis.
Immunoglobulin expression on B cell surface
Purified B cells were stained with different combi-
nations of the following monoclonal antibodies (BD,
Pharmingen): anti-IgDFITC or anti-IgDPE, anti-
IgGFITC or anti-IgGPECy7, anti-IgMPE, anti-IgAAPC,
anti-CD27PE or anti-CD27APC. Cells were washed
twice and analyzed. All measurements were made
with a FACSCalibur flow cytometer (Becton–Dick-
inson, San Jose, CA, USA) with the same instrument
setting. At least 104 cells were analyzed using
CellQuestPro (Becton–Dickinson, San Jose, CA,
USA) software.
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B cell activation and intracellular cytokine
detection
Stimulation of B cells with anti-CD40 and interleukin
(IL)-4 for intracellular IL-10 and tumor necrosis
factor (TNF)-a cytokine detection
Separated B cells (1 9 105/200 ll) were cultured
in 96-well round-bottom plates and activated with
1 lg/ml of anti-human CD40 (BD, Pharmingen) and
10 ng/ml of human recombinant IL-4 (BD, Pharmin-
gen) with or without 2 lg/ml of anti-BCR [F(ab’)2]
(Jackson ImmunoResearch Laboratories, Inc, Phila-
delphia) for 48 h, at 37C (CO2 5%). Cells were
harvested, washed and stained with anti-IgDFITC or
anti-IgDPE, (BD, Pharmingen) and anti-CD27APC
(BD, Pharmingen). After two washes, cells were
fixed with 100 ll of Perm & Fix Solution A (Caltag
Burlingame), washed and permeabilized with 100 ll
of Perm & Fix Solution B (Caltag Burlingame).
Finally cells were stained with anti TNF-aFITC (BD,
Pharmingen) or anti IL-10PE (BD, Pharmingen),
washed and analyzed.
Stimulation of PBMCs with CpG/phorbol myristate
acetate (PMA)/ionomycin for B cell IL-10 production
For intracellular IL-10 analysis, PBMCs (106 cells/ml)
were suspended in complete medium with or without
CpG-B 2006 (3 lg/ml, Tib Molbiol), PMA (50 ng/mL),
ionomycin (1 mM) and monensin (2 mM; eBioscience)
in 24-well flat-bottom plates for 5 h, at 37C (CO2 5%)
(Bouaziz et al. 2010). Cells were harvested, washed
and stained with anti-IgDFITC, anti-CD19PerCP and
anti-CD27APC (BD, Pharmingen). Then cells were
fixed with 100 ll of Perm & Fix Solution A (Caltag
Burlingame), washed twice and permeabilized with
100 ll of Perm & Fix Solution B (Caltag Burlin-
game). Finally cells were stained with anti IL-10PE
(BD, Pharmingen), washed and analyzed.
Somatic hypermutation assay
B cells, separated by MACS (1 9 107), were stained
with 20 ll of anti IgGFITC, anti-IgDPE and anti-
CD27APC (BD, Pharmingen), then washed and resus-
pended in 1 ml of PBS/BSA (0,5%). After defining the
sorting region gate (IgG?IgD-CD27- or IgG?IgD-
CD27?) we optimized the sample concentration,
verifying the event rate and the sort rate to maximise
the efficiency of cell separation. cDNA was synthesised
from IgG?IgD-CD27? and IgG?IgD-CD27- cells.
Immunoglobulin IgG genes were isolated by semi-
nested PCR and sequenced using the Roche Titanium
platform as previously reported (Wu et al. 2010).
Briefly: a 25-ll PCR1 reaction mix contained 6.25 ll
of cDNA, 0.625 U Phusion DNA polymerase (NEB),
200 lM each dNTPs, 41.75 nM 50 primer (mix of
IGHV gene family 1–6 primers) and 250 nM constant
region Cgamma primer. A 20 ll of PCR2 reaction
mix comprising 0.5U Phusion DNA polymerase,
200 lM each dNTPs, 41.75 nM each 50 primer mix
(multiplex-identifier (MID)-linked IGHV family 1–6
primers) and 250 nM MID-linked Cgamma primer
was used to amplify 2 ll of PCR1 products. PCR
thermalcycling conditions are as follows: 98C for
(30 s), 15 (PCR1) or 20 (PCR2) cycles of 98C (10 s);
58C (15 s); 72C (30 s), and 1 cycle of 72C (5 min).
Purification of PCR products in sufficient quantity for
sequencing and the downstream data processing
pipeline are as previously published (Wu et al.
2010). Mutational analysis of VH IgG transcripts
was done by comparison with germline sequences
from the ImMuno-GeneTics (IMGT) database (avail-
able at http://imgt.cines.fr_). The number of mutated
nucleotides was determined for each transcript after
their alignment with the germline gene.
Statistical analysis
Values (percentage or MFI), given as the mean ± SD
or SE, were compared using one-way analysis of
variance (ANOVA). Differences were considered
significant when a P value \ 0.05 was obtained by
comparison between the different groups.
Results
Surface immunoglobulin of DN cells
As we are interested in B cell memory, and partic-
ularly in DN (IgD-CD27-) B cells, we have
evaluated the immunoglobulin expression (IgM, IgG
or IgA) on B cells, gated on the basis of the presence/
absence of IgD and CD27. Concerning naı¨ve
(IgD?CD27-) and memory unswitched (IgD?
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CD27?) B cells, we found that all these cells are
IgM? (not shown). Most of the DN cells are IgG?
(more than 60%), others (more than 20%) are IgA
and few of them (less than 10%) are IgM? (Fig. 1a).
We did not find any age-related differences in the
relative expression of IgM, IgG or IgA isotypes in
memory DN B cells (IgD-CD27-) (Table 1). In
contrast, the proportion of IgG, IgA and IgM memory
B cells in the classical switched memory compart-
ment (IgD-CD27?) is different between young and
old (Fig. 1b), with a significant decrease of IgM?
IgD-CD27? memory B cells in old subjects (Table 2).
This is in agreement with previous data that have
demonstrated a reduction of IgM ‘‘only’’ memory B
cells in the elderly (Shi et al. 2005). We show a slight
increase in the expression of IgG and IgA on
switched memory B cells but this did not reach
significance, although the relative proportions of the
different isotypes of memory cells mirrors the
relative proportion of serum immunoglobulin of
the different isotypes (Paganelli et al. 1992; Listı`
et al. 2006).
Intracellular cytokine production
In order to assess whether the modifications of the B
cell subpopulations described in the elderly might in
turn affect the cytokine environment of the aged we
have evaluated TNF-a (pro-inflammatory) and IL-10
(anti-inflammatory) production by naı¨ve and memory
B cells. To this purpose magnetically sorted B
lymphocytes from the two age groups of donors
were stimulated by anti-CD40/IL-4 (Frasca et al.
2008). We analyzed the production of IL-10 and
TNF-a by CD27? or CD27- B cells from young and
old donors. As shown in Fig. 2, there is a different
pattern of cytokine production between the two age
groups: in fact, CD27- B cells from the elderly
produce significantly higher levels of both IL-10 and
TNF-a when compared to CD27- B cells from the
young, whereas in the CD27? B cell subset the young
donors produce the higher levels of these cytokines.
Evaluating the specific contribution of each B cell
subset to IL-10 and TNF-a production (Table 3),
most IL-10 (a) and TNF-a (b) production is from
unswitched memory B cells in both young and elderly
subjects. Interestingly, naı¨ve B cells from old donors
produce a large amount of these cytokines,
significantly higher than those produced by naı¨ve B
cells from young donors.
In a recent paper by Bouaziz et al. (2010), the
authors tested the ability of blood B cells to produce
IL-10 after a short stimulation with CpG, PMA and
Ionomycin, showing that the combined action of
these stimuli was the most potent inducer of IL-10
production. We have performed this kind of analysis
in our young and elderly subjects and we show that,
unlike the CD40 stimulation, the main IL-10 produc-
ing cells are IgD?CD27? memory unswitched B cells
and IgD?CD27- naı¨ve B cells in both young and
elderly people with no significant differences
between the two groups (Table 4). So the non-
physiological stimulus activates more naı¨ve cells than
the physiological stimulus in the young donors.
Neither the classical switched memory nor the double
negative B cells are activated by the non-physiolog-
ical ‘‘strong stimulus’’ at any age.
Somatic hypermutation in DN (CD19?IgG?
IgD-CD27-) cells
In order to evaluate the effect of ageing on B cell
receptor hypermutation in memory B cell subsets, we
have evaluated the number of somatic mutations in
the IgG VH regions of CD27? and CD27- B cells in
young and elderly donors. Our results show that, both
in young and in elderly donors, DN memory B cells
have significantly fewer mutations than CD19?Ig-
G?IgD-CD27? classical switched memory B lym-
phocytes (Fig. 3a), although the rate of mutations
observed in the DN CD19?IgG? IgD-CD27- B cell
subset of old people is significantly reduced when
compared to the rate of mutations observed in DN
cells from young subjects (Fig. 3b). Moreover, there
was no significant difference between the two age
groups in the CD27? memory B cell compartment.
Discussion
The ageing of the immune system involves both cell-
mediated and humoral immunity as well as aspects of
innate immunity. Most researchers have studied the
impairment of cell-mediated immune response in the
elderly, although B cell function is also modified with
age (Cancro et al. 2009; Bulati et al. 2011; Frasca and
Blomberg 2011).
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Fig. 1 a A typical
experiment showing IgM,
IgG or IgA expression on
gated IgD-CD27- (DN) B
cells in young and elderly
donors. No difference in
expression was observed
between the two groups
analyzed. b A typical
experiment showing IgM,
IgG or IgA expression on
gated IgD-CD27?
(memory switched) B cells
in young and elderly
donors. We show significant
decrease of
IgM?IgD-CD27? memory
B cells in old subjects
studied when compared to
young
Biogerontology (2011) 12:473–483 477
123
In a previous paper (Colonna-Romano et al. 2009)
we have demonstrated the expansion of a B memory
subpopulation lacking the classic memory marker
CD27 in elderly people, namely double negative
(DN, IgG?IgD-CD27-) CD19? cells. This kind of
memory B cell has also been described by Fecteau
et al. (2006) in healthy donors, Wei et al. (2007) in
active Lupus patients and by Sanz et al. (2008) in
healthy subjects challenged with respiratory syncitial
virus (RSV). These cells are probably the conse-
quence of a persistent stimulation of the immune
system, for example in patients with lupus (Anolik
et al. 2004) where the expansion of these cells
correlates positively with the clinical manifestations
Table 1 IgM, IgG and IgA expression on gated IgD-CD27- (DN) B cells from young and old donors
DN
(IgD-CD27-) B cells
Young (n = 25)
(% Mean±SD)
Elderly (n = 29)
(% Mean±SD)
P value
IgM? 6.64 ± 2.6 5.8 ± 3.1 0.7
IgG? 63.7 ± 16.6 68.2 ± 17.3 0.9
IgA? 23.8 ± 9.6 20.8 ± 10.9 0.8
No significant differences have been observed between the two groups studied
Table 2 IgM, IgG and IgA expression on gated IgD-CD27? (memory switched) B cells from young and old donors
Memory switched
(IgD-CD27-) B cells
Young (n = 25)
(% Mean±SD)
Elderly (n = 29)
(% Mean±SD)
P value
IgM? 18.6 ± 4.7 8.1 ± 3.8 0.03
IgG? 49.6 ± 8.1 57.2 ± 6.7 0.6
IgA? 37.3 ± 7.7 41.5 ± 8.9 0.8
P value \ 0.05, obtained by one way ANOVA nonparametric test, is considered significant
Fig. 2 Evaluation of pro- and anti-inflammatory cytokines
production by CD27? and CD27- B lymphocytes in 10 young
(Y) and 10 old (O) donors with or without IL-4/CD40
activation. a CD27- B cells from elderly subjects produce
significantly higher levels of TNF- a and IL-10, both at basal
level (TNF-a P value = 0.003, IL-10 P value = 0.02) and
after activation (TNF-a P value = 0.002, IL-10 P value =
0.002), when compared with young donors. b Viceversa,
CD27? B cells from young subjects produce higher levels of
studied cytokines, when compared with old donors: we found,
at basal level, significant differences between two age groups
only for IL-10 (P value = 0.01), while, after activation, both
cytokines have significant differences (TNF-a P value = 0.04;
IL-10 P value = 0.01). (P value \ 0.05, obtained by one way
ANOVA nonparametric test, is considered significant)
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of the disease (Wei et al. 2007). Intriguingly we have
reported (Colonna-Romano et al. 2010) that DN B
cells are not increased in a ‘‘genetically advantaged’’
cohort of centenarian’s offspring that also show a
higher level of naı¨ve B cells compared to their age-
matched controls (70–80 years old).
In the present paper we have further studied
memory/naı¨ve B cells in the elderly, evaluating surface
Immunoglobulin (sIg), production of pro-and anti-
inflammatory cytokines and somatic hypermutation.
Our data confirms a previous report of reduced IgM
only (IgM?IgD-CD27?) memory B cells in old
subjects (Shi et al. 2005), although the compensatory
increase in the expression of IgG and IgA on switched
memory CD27? B cells did not reach significance. No
significant differences were observed in the expres-
sion of the different immunoglobulin classes between
old and young donors in DN B cells.
It has been described (Duddy et al. 2004; Duddy
et al. 2007; Sanz et al. 2007, 2008; Lund 2008) that
Table 3 IL-10 and TNF-a production among B cell subsets in 10 young (Y) vs 10 old (O) donors after CD40/IL-4 activation
Percentage of IL-10 producing B cells
CD40/IL-4 P
Y O
(a)
Naive 15.1 ± 7 40.8 ± 5.1 0.04
Memory unswitched 79.6 ± 9.8 58.4 ± 4.9 0.2
Memory switched 3.1 ± 1.8 0.5 ± 0.2 0.2
DN 2 ± 1 0.2 ± 0.1 0.1
Percentage of TNF-a producing B cells
CD40/IL-4 P
Y O
(b)
Naive 7 ± 3 24.9 ± 1.9 0.01
Memory unswitched 87.8 ± 4.8 72.3 ± 9 0.2
Memory switched 4.6 ± 3 1.6 ± 0.9 0.4
DN 0.5 ± 0.1 1.1 ± 0.8 0.5
In table (a) and (b) it is shown as the major contribute on the production of the two studied cytokines is given by unswitched memory
B cells in both young and elderly subjects. Moreover, among the IL-10 and TNF-a producing cells from elderly donors, we show a
significant amount of naı¨ve B cells. Data are expressed as percentage (Mean ± SD). (P value \ 0.05, obtained by one way ANOVA
nonparametric test, is considered significant)
Table 4 IL-10 producing cells among B cell subsets in 10 young (Y) vs 10 old (O) donors after CpG/PMA/IONOMYCIN activation
Distribution of B populations inside IL-10 producing B cells
CpG/PMA/IONOMYCIN P
Y O
Naive 28.6 ± 4.6 37.7 ± 15.4 0.6
Memory unswitched 64.3 ± 9.2 59.3 ± 16 0.8
Memory switched 5.6 ± 4 1.4 ± 0.2 0.3
DN 1.4 ± 0.6 1.6 ± 0.7 0.9
Data are expressed as percentage (Mean ± SEM). (P value \ 0.05, obtained by one way ANOVA nonparametric test, is considered
significant)
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naı¨ve and memory B cells are able to produce
different levels of pro- and anti-inflammatory cyto-
kines (TNF-a and IL-10). Moreover it is known that
elderly people show a pro-inflammatory micro-envi-
ronment that has been related to the increased risk of
morbidity and mortality (Licastro et al., 2005; Vasto
et al. 2007). With this in mind we have evaluated
whether changes in the relative proportions of
different B cell populations could affect the cytokine
environment. Here we show that in both young and
old donors the physiological (a-CD40 and IL4)
stimulation of B cells induces a good IL-10 and
TNF-a production by unswitched (IgD?CD27?)
memory B cells. Interestingly, in the elderly, naı¨ve
B cells are also highly activated to produce cytokines
under these conditions. Not all studies are in agree-
ment with respect to the identification of B cell
subpopulations responsible for IL-10 (a very relevant
anti-inflammatory cytokine) production in humans. In
fact this feature has been attributed to both memory
(CD27?, principally IgD?CD27?) (Amu et al. 2007)
and immature transitional (CD38highCD24high) B cell
pools (Blair et al. 2010). On the other hand, Bouaziz
et al. (2010), have shown that both IgD?CD27-
(classically naı¨ve) and IgD?CD27? (memory uns-
witched) B cells participate in IL-10 production by
evaluating the differential expression of IgD and
CD27, or CD38 and CD24 on IL-10-producing B
cells after a ‘‘strong’’ (CpG/PMA/Ionomycin) activa-
tion. In our study we confirm that the ‘‘strong’’
activation induces IL-10 production by IgD?CD27-
naı¨ve and IgD?CD27? unswitched memory B cells in
the control (young donors), we also show that the old
donors behave similarly in that both naı¨ve and
unswitched memory B cells from old subjects are
activated to produce IL-10. Taken together our IL-10
production data might suggest that naı¨ve B cells from
young donors need an adequate stimulus (e.g. TLR
engagement) to be activated ‘‘in vitro’’ but B cells
from old subjects have higher ‘‘in vitro’’ basal levels
of IL-10 and TNF-a production (not shown) and
therefore may already be basally activated, possibly
by bacteria (which can be harbored in places such as
the urinary tract) or viruses (such as CMV). It has
been demonstrated (Lampropoulou et al. 2008) that
TLR2, TLR4 and TLR9 engagement induces IL-10
production by splenic B cells in the mouse. In
addition, as proposed by Rieger and Bar-Or (2008),
IL10 production by naı¨ve B cells may act as a control
mechanism to prevent the exacerbation of inflamma-
tion in an autoimmune context, whereas IL10
production by memory B cells might be active in
Fig. 3 Evaluation of somatic mutations on IgG VH regions in
3 young (Y) and 3 old (O) subjects. a Both in young and in the
elderly donors, CD19?IgG?IgD-CD27- (CD27-) B cells have
shown significantly fewer mutations than CD19?Ig-
G?IgD-CD27? (CD27?) B lymphocytes. b Frequency of
somatic mutations on CD19?IgG?CD27-IgD- (DN) B cells
evaluated in young and old subjects. The latter show a
significantly reduced rate of mutations when compared to the
former (P value \ 0.05, obtained by one way ANOVA
nonparametric test, is considered significant). The number of
sequences analyzed are summarized in the bottom of the figure
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the resolution of the disease. In the evaluation of
these results we have kept in mind that transitional
(CD24highCD38high) B cells are also present in the
IgD?CD27- (naı¨ve) gate. These are known to have
regulatory properties by production of the anti-
inflammatory cytokine IL-10 (Blair et al. 2010), so
it could be hypothesized that in the elderly there is an
increased number of IL-10-producing transitional B
cells with regulatory function. We suggest that the
cytokines produced in young donors are active in
modulating the size of immune response, whereas in
the elderly the higher production of cytokines by
naı¨ve B cells may be due to a basal overstimulation of
the immune-inflammatory system.
To gain insight into the biological significance of
the different naive and memory B cell subsets, we
have studied the level of mutation in the V region of
IgG and showed that CD27? B cells have a signif-
icant higher number of somatic mutations both in
young and old donors compared with the CD27- B
cells. No significant differences in the level of
hypermutation in CD27? cells are observed between
the two age groups. In contrast, the rate of mutations
in the DN (IgG?IgD-CD27-) B cell population is
lower in the elderly. It is well known that memory B
cells are characterized by the high rate of somatic
hypermutation, and that this event occurs in the
germinal center and that it involves T-B cell inter-
action. So our results might be due to different
circumstances. As previously published (Bulati et al.
2011), and as shown here, IgG?IgD-CD27- DN B
cells show a low frequency of somatic mutation, and
this supports the theory that these cells might emerge
independently from T cell help, or from CD40-
CD154 interaction. Alternatively, the reduced amount
of somatic mutation in the old group might be due to
reduced co-stimulation of B cells in the elderly
(Weiskopf et al. 2009) as a result of intrinsic T cell
defects, although this would also affect the rate of
mutation in the classical switched memory
(IgG?IgD-CD27?) B cells which is not seen here.
This leads us to the hypothesis that there is a large
population of DN cells that are unrelated to classical
memory B cells. The increase of the double negative
memory B cells in the elderly (Colonna-Romano
et al. 2009; Bulati et al. 2011), together with the
reduced rate of mutation shown here, might be due to
the disconnected generation of these cells from
germinal centers, as it has been demonstrated that
ageing negatively affects the germinal center forma-
tion in secondary lymphoid tissues (William et al.
2002; Frasca et al. 2005).From this and our previous
papers (Colonna-Romano et al. 2009, 2010) we can
conclude that DN B lymphocytes are exhausted cells.
In fact they are not activated by anti-CD40/IL4, or by
CpG/PMA/Ionomycin and behave differently as
CMV-specific effector- memory CD8 lymphocytes.
These are T cells usually supposed to be terminally
differentiated and unable to proliferate, although they
can be activated when appropriately stimulated ‘‘in
vitro’’ (Waller et al. 2007). It might be interesting to
know whether these cells are a by product of time-
enduring stimulation by an unknown, infectious
agent. One possible candidate would be CMV, since
Chidrawar et al. (2009) have demonstrated that CMV
infection in the elderly influences not only T
lymphocytes (Pita-Lopez et al. 2009; Pawelec et al.
2009, 2010), but also negatively affects B cells.
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